- Home
- DescriptionNews
10 orphan drugs added to the national drug list
10 orphan drugs added to the national drug list
Ten orphan drugs are added to the National List of Essential Medicines , allowing Thai patients living with rare diseases to access these drugs for free.
On Jul 4, the National Health Security Board(NHSB) chaired by Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul agreed with health experts’ suggestion to include 10 drugs into the National List of Essential Medicines’ category E(2).
With the drugs’ inclusion in the list, the NHSO could legally purchase the drugs and distribute them to hospitals caring for patients with rare diseases.
Category E(2) includes the orphan drug list covered by the government’s healthcare schemes, providing patients equitable access to medications despite their high prices.
The 10 drugs are:
1) Posaconazole, a triazole antifungal medication used to prevent certain fungus infections, including mucormycosis, in patients with a weakened immune system.
2) Linezolid, a medication used to treat infections, including enterovirus infection.
3) Sofosbuvir, Velpatasvir and Ribavirin used to treat Hepatitis C.
4) Octreotide acetate, a medication used to treat patients with thyrotropin secreting pituitary adenoma or benign tumors of the pituitary gland.
5) Bevacizumab injection, a medication used to treat babies born prematurely and with retinopathy.
6) Voriconazole, a medication used to treat invasive fungal infection caused by Trichosporon spp.
7) Rituximab injection used to treat neuromyelitis optica spectrum disorder, a rare condition where the immune system damages the spinal cord and the nerves of the eyes.
8) Nitisinone, a medication used to slow the effects of hereditary tyrosinemia type 1
9) Cysteamine bitartrate, a medication used to treat Nephropathic Cystinosis or autosomal recessive metabolic disorder
10) Sapropterin, a medication used to treat Phenylketonuria.
.jpg)
Dr Prasobsri Ungthavorn, chairman of the NHSO’s subcommittee for scopes and types of health services, said that the inclusion of orphan drugs into the National List of Essential Medicines is the mechanism that allows patients with rare diseases to access medications despite their high cost.
The selections of the drugs in the list are based on evidence-based and cost-effective studies, she said.
They don’t add financial burdens to the government but ensure patients’ access to quality and effective treatment.
////////////////////
Ten orphan drugs are added to the National List of Essential Medicines , allowing Thai patients living with rare diseases to access these drugs for free.
On Jul 4, the National Health Security Board(NHSB) chaired by Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul agreed with health experts’ suggestion to include 10 drugs into the National List of Essential Medicines’ category E(2).
With the drugs’ inclusion in the list, the NHSO could legally purchase the drugs and distribute them to hospitals caring for patients with rare diseases.
Category E(2) includes the orphan drug list covered by the government’s healthcare schemes, providing patients equitable access to medications despite their high prices.
The 10 drugs are:
1) Posaconazole, a triazole antifungal medication used to prevent certain fungus infections, including mucormycosis, in patients with a weakened immune system.
2) Linezolid, a medication used to treat infections, including enterovirus infection.
3) Sofosbuvir, Velpatasvir and Ribavirin used to treat Hepatitis C.
4) Octreotide acetate, a medication used to treat patients with thyrotropin secreting pituitary adenoma or benign tumors of the pituitary gland.
5) Bevacizumab injection, a medication used to treat babies born prematurely and with retinopathy.
6) Voriconazole, a medication used to treat invasive fungal infection caused by Trichosporon spp.
7) Rituximab injection used to treat neuromyelitis optica spectrum disorder, a rare condition where the immune system damages the spinal cord and the nerves of the eyes.
8) Nitisinone, a medication used to slow the effects of hereditary tyrosinemia type 1
9) Cysteamine bitartrate, a medication used to treat Nephropathic Cystinosis or autosomal recessive metabolic disorder
10) Sapropterin, a medication used to treat Phenylketonuria.
Dr Prasobsri Ungthavorn, chairman of the NHSO’s subcommittee for scopes and types of health services, said that the inclusion of orphan drugs into the National List of Essential Medicines is the mechanism that allows patients with rare diseases to access medications despite their high cost.
The selections of the drugs in the list are based on evidence-based and cost-effective studies, she said.
They don’t add financial burdens to the government but ensure patients’ access to quality and effective treatment.
////////////////////
